What team are you on?
That’s what we’ve degraded to at this point, isn’t it?
You’re right. They’re wrong. There’s no in-between.
But, that’s not entirely accurate.
Nobody on Capitol Hill will admit it, but there’s one issue that BOTH sides of the political spectrum can agree on.
It’s the one thing that has brought those bitter political rivals together. And if they don’t pony up trillions right now, we’re all going to be in a lot of trouble.
Things get even better for individual investors like us, too, especially considering that the investment herd still hasn’t caught on yet.
That early window of opportunity is closing faster than you might expect.
Years ago, I told my readers that America was crumbling.
Today, that sentiment is truer than ever.
Before your indignation begins to boil as you decide which team I’m on, you should know that I’m not waxing some metaphorical sentiment.
We are literally wasting away.
Look around you and you’ll most certainly agree.
Go ahead, take a glance, but look closely.
I’ll even help you cheat a little. Every couple of years, the American Society of Civil Engineers (ASCE) puts out a report grading America’s infrastructure.
And for the last 20 years, the absolute best grade we’ve gotten was a D+.
That doesn’t scare you?
What if I told you that the number of dams in the United States that are at risk of failure –– currently over 4,000 of them –– has more than doubled since 1999?
Or that over one-third of all dam failures that have taken place throughout U.S. history occurred within the last 15 years?
Not specific enough for you? Or perhaps it’s that dam failures don’t scare you?
Well, the next time you cross a river, try not to think about the fact that almost four out of every 10 bridges in America need to be repaired and that there are nearly 50,000 structurally deficient bridges across the country.
Now, remember that people cross our bridges 178 million times every day!
Our analysts have traveled the world over, dedicated to finding the best and most profitable investments in the global energy markets. All you have to do to join our Energy and Capital investment community is sign up for the daily newsletter below.
My veteran readers know this rant of mine all too well.
More importantly, they know that trillions of dollars will have to be injected into America’s failing infrastructure in the years ahead.
And here’s the best part for us –– all of it is up for grabs!
Investor Jackpot: $4.5 Trillion up for Grabs
We’re talking about some serious cash here.
The ASCE put a $4.5 TRILLION price tag on this burgeoning infrastructure crisis… and we’re going to have to spend it within the next five years!
That’s the cost for neglecting our critical infrastructure, from dams and bridges to pipelines, roads, and railroads.
Roughly $171 billion will have to be spent on bridges alone, and I should note that our bridges were in better shape than others.
As I said, both sides in Washington are on board. Right now, they’re both racing to put their infrastructure bills together for this contentious election year.
The House’s $1.5 trillion in bills are starting to leak.
President Trump is pushing his own $1 trillion infrastructure bill.
Here’s the catch: Whatever they negotiate won’t be enough.
This isn’t a happy, feel-good story.
It’s an opportunity.
Stay tuned because we’re just starting to scratch the surface of America’s infrastructure crisis.
Until next time,
A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing’s Energy Investor and Technology and Opportunity.
For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.
Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.